Latest Insider Transactions at Heron Therapeutics, Inc. (HRTX)
This section provides a real-time view of insider transactions for Heron Therapeutics, Inc. (HRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of HERON THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of HERON THERAPEUTICS, INC. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2020
|
John Poyhonen President & CCO |
BUY
Other acquisition or disposition
|
Direct |
637
+3.28%
|
$7,007
$11.65 P/Share
|
|
Apr 30
2020
|
Barry D Quart Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,158
+1.28%
|
$13,896
$12.12 P/Share
|
|
Oct 04
2019
|
Tang Kevin C Director |
BUY
Open market or private purchase
|
Indirect |
285,714
+4.7%
|
$4,857,138
$17.5 P/Share
|
|
Sep 12
2018
|
Tang Kevin C Director |
SELL
Open market or private sale
|
Indirect |
2,695,000
-31.61%
|
$94,325,000
$35.75 P/Share
|
|
Mar 29
2018
|
Tang Kevin C Director |
BUY
Open market or private purchase
|
Indirect |
192,308
+2.21%
|
$5,000,008
$26.0 P/Share
|
|
Nov 04
2016
|
Barry D Quart Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
600
+0.64%
|
-
|
|
Nov 04
2016
|
Barry D Quart Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
600
-100.0%
|
-
|
|
Jun 20
2015
|
Barry D Quart Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
600
+50.0%
|
-
|